High prevalence but limited evidence in complementary and alternative medicine: Guidelines for future research

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Fischer, Felix H ^a   Lewith, George ^b   Witt, Claudia M ^a,c   Linde, Klaus ^d   von Ammon, Klaus ^e   Cardini, Francesco ^f   Falkenberg, Torkel ^g,h   Fønnebø, Vinjar ⁱ   Johannessen, Helle ^j   Reiter, Bettina ^k   Uehleke, Bernhard ^l   Weidenhammer, Wolfgang ^d   Brinkhaus, Benno ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF BERN   (Switzerland)

^f Agency for Health and Social Care of Emilia Romagna   (Italy)

^g KAROLINSKA INSTITUTE   (Sweden)

^h IC The Integrative Care Science Center   (Sweden)

ⁱ UNIVERSITY OF TROMSØ   (Norway)

^j UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^k International Academy for Holistic Medicine   (Austria)

^l UNIVERSITY HOSPITAL ZURICH   (Switzerland)

more..

Author keywords

Comparative effectiveness research; Complementary and alternative medicine; Qualitative studies; Randomized clinical trials; Research strategy; Safety

Indexed keywords

ALTERNATIVE MEDICINE; COOPERATION; EUROPE; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH SERVICE; HUMAN; PREVALENCE; RESEARCH; UTILIZATION;

COMPLEMENTARY THERAPIES; COOPERATIVE BEHAVIOR; DELIVERY OF HEALTH CARE; EUROPE; EVIDENCE-BASED MEDICINE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PREVALENCE; RESEARCH;

EID: 84893190693     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-46     Document Type: Letter

References (27)

1. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998, 280:1569-1575. 10.1001/jama.280.18.1569, 9820257.
2. Härtel U, Volger E. Use and acceptance of classical natural and alternative medicine in Germany-findings of a representative population-based survey. Forsch Komplementarmed 2004, 11:327-334.
3. Bücker B, Groenewold M, Schoefer Y, Schäfer T. The use of complementary alternative medicine (CAM) in 1 001 German adults: results of a population-based telephone survey. Gesundheitswesen 2008, 70:e29-e36. 10.1055/s-2008-1081505, 18785094.
4. Bodeker G, Ong CK, Grundy C, Burford G, Shein K. WHO Global Atlas of Traditional, Complementary and Alternative Medicine 2005, Kobe: World Health Organization.
5. Committee on the Use of Complementary and Alternative Medicine by the American Public Complementary and Alternative Medicine in the United States 2005, Washington, DC: National Academies Press (US), Committee on the Use of Complementary and Alternative Medicine by the American Public.
6. Weidenhammer W, Lewith G, Falkenberg T, Fønnebø V, Johannessen H, Reiter B, Uehleke B, von Ammon K, Baumhöfener F, Brinkhaus B. EU FP7 project " CAMbrella" to build European research network for complementary and alternative medicine. Forsch Komplementarmed 2011, 18:69-76.
7. Wiesener S, Falkenberg T, Hegyi G, Hök J, Roberti di Sarsina P, Fønnebø V. Legal status and regulation of complementary and alternative medicine in Europe. Forsch Komplementarmed 2012, 19:29-36.
8. Nissen N, Schunder-Tatzber S, Weidenhammer W, Johannessen H. What attitudes and needs do citizens in europe have in relation to complementary and alternative medicine?. Forsch Komplementarmed 2012, 19:9-17.
9. Eardley S, Bishop FL, Prescott P, Cardini F, Brinkhaus B, Santos-Rey K, Vas J, von Ammon K, Hegyi G, Dragan S, Uehleke B, Fønnebø V, Lewith G. A systematic literature review of complementary and alternative medicine prevalence in EU. Forsch Komplementarmed 2012, 19:18-28.
10. Fischer HF, Junne F, Witt C, von Ammon K, Cardini F, Fønnebø V, Johannessen H, Lewith G, Uehleke B, Weidenhammer W, Brinkhaus B. Key issues in clinical and epidemiological research in complementary and alternative medicine - a systematic literature review. Forsch Komplementarmed 2012, 19:51-60.
11. Falkenberg T, Lewith G, Roberti di Sarsina P, von Ammon K, Santos-Rey K, Hök J, Frei-Erb M, Vas J, Saller R, Uehleke B. Towards a Pan-European definition of complementary and alternative medicine - a realistic ambition?. Forsch Komplementarmed 2012, 19:6-8.
12. Von Ammon K, Frei-Erb M, Cardini F, Daig U, Dragan S, Hegyi G, Roberti di Sarsina P, Sörensen J, Lewith G. Complementary and alternative medicine provision in Europe - first results approaching reality in an unclear field of practices. Forsch Komplementarmed 2012, 19:37-43.
13. Hök J, Lewith G, Weidenhammer W, Santos-Rey K, Fønnebø V, Wiesener S, Falkenberg T. International development of traditional medicine / complementary and alternative medicine research - What can Europe learn?. Forsch Komplementarmed 2012, 19:44-50.
14. Von EE, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J. Strobe Initiative: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007, 147:573-578. 10.7326/0003-4819-147-8-200710160-00010, 17938396.
15. Reiter B, Baumhöfener F, Dlaboha M, Odde Madsen J, Regenfelder S, Weidenhammer W. Building a sustainable complementary and alternative medicine research network in Europe. Forsch Komplementarmed 2012, 19:61-68.
16. Fonnebo V, Grimsgaard S, Walach H, Ritenbaugh C, Norheim AJ, MacPherson H, Lewith G, Launsø L, Koithan M, Falkenberg T, Boon H, Aickin M. Researching complementary and alternative treatments-the gatekeepers are not at home. BMC Med Res Methodol 2007, 7:7. 10.1186/1471-2288-7-7, 1800863, 17291355.
17. Tunis S, Stryer D, Clancy C. Practical clinical trials. JAMA 2003, 290:1624-1632.
18. Our Questions, Our Decisions: Standards for Patient-centered Outcomes Research. http://pcori.org/assets/MethodologyReport-Comment.pdf.
19. VanLare JM, Conway PH, Sox HC. Five next steps for a new national program for comparative-effectiveness research. N Engl J Med 2010, 362:970-973. 10.1056/NEJMp1000096, 20164480.
20. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. Br Med J 2008, 337:979-983.
21. Hoffman A, Montgomery R, Aubry W, Tunis SR. How best to engage patients, doctors, and other stakeholders in designing comparative effectiveness studies. Health Aff 2010, 29:1834-1841.
22. Kaptchuk TJ. The Placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance?. Ann Intern Med 2002, 136:817-825. 10.7326/0003-4819-136-11-200206040-00011, 12044130.
23. Linde K, Niemann K, Schneider A, Meissner K. How large are the nonspecific effects of acupuncture? A meta-analysis of randomized controlled trials. BMC Med 2010, 8:75. 10.1186/1741-7015-8-75, 3001416, 21092261.
24. Haake M, Muller H, Schade-Brittinger C, Basler H, Schafer H, Maier C, Endres H, Trampisch H, Molsberger A. German Acupuncture Trials (GERAC) for chronic low back pain: randomized, multicenter, blinded, parallel-group trial with 3 groups. Arch Intern Med 2007, 167:1892-1898. 10.1001/Archinte.167.17.1892, 17893311.
25. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev 2009, (1):CD001218.
26. Paterson C, Dieppe P. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. Br Med J 2005, 330:1202-1205.
27. NCCAM Strategic Plan 2011-2015. http://nccam.nih.gov/about/plans/2011.